About
Company Strategy
Group Structure
Board of directors
Management
Career
Contacts
Development
Drugs
Medical devices
Medical services
Biotech valuation
Activity
Areas of activities
Research and development (R&D) stages
Ecosystem
Acceleration
Commercialization
Investor
Disclosure of information
News
En
RU
CN
Главная
News
News
News, press releases, events, publications
All categories
All categories
News
Press releases
Press about us
Portfolio
Portfolio
Nextgen
Gemabank
Biotechnology Developments
Genetico
Betuvax
Histograft
Genotarget
Reprobank
Vitacel
29.05.2025
News
Artgen Biotech at Startup Village 2025: company’s developments in Dmitriy Medvedev’s focus
26.05.2025
Press releases
A Russian gene therapy drug was presented to the European Society for Vascular Surgery
12.05.2025
Press releases
Gemabank will increase biomaterial extraction and storage cost
07.05.2025
Press releases
RBT will continue independent development of combined influenza and coronavirus vaccine
28.04.2025
Press releases
Artgen Biotech operating results for 2024 according to the IFRS
18.04.2025
Press releases
By 2030, the global NGS market will grow to 35.4B US dollars
28.03.2025
Press releases
Genetico’s income increased by 23% in 2024
1
2
3
4
…
19
Up
About the Company
About
Company Strategy
Group Structure
Board of Directors
Management
Career
Contacts
Development Portfolio
Drugs
Medical Devices
Medical Services
Activity
Areas of activities
Research and development (R&D) stages
Ecosystem
Acceleration
Commercialization
Biotech Valuation
Investors
Disclosure of information
